Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Natus Medical Inc (NASDAQ: BABY) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Natus Medical Inc (NASDAQ: BABY) concerning whether a series of statements by Natus Medical Inc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On April 4, 2016, Natus Medical revealed lower-than-expected preliminary for the quarter ended March 31, 2016. The Company's CEO stated that “Pushouts of key orders in both our international and domestic markets led to weaker than expected revenue late in the first quarter.”

Following this news, NASDAQ: BABY dropped over 24% on April 4, 2016.

Based in Pleasanton, CA, and founded in 1987 Natus Medical Inc engages in designing, manufacturing, and marketing newborn care and neurology healthcare products and services.

 If you purchased shares of Natus Medical Inc (NASDAQ: BABY) on or before April 4, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185